Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) : Prospective study for Classification of newly diagnosed Hematological Malignancy

Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) : Prospective study for Classification of newly diagnosed Hematological Malignancy - JPLSG-CHM-14

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016174

Enrollment

10000

Registered

2015-01-10

Start date

2015-01-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Hematological Malignancy

Interventions

Collection of tumor and normal samples

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hematological malignancy or suspected hematological malignancy. Written informed consent obtained from patient or guardian.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Central examination/diagnosis Information at the time of the initial examination and recurrence	—

Secondary

Measure	Time frame
Collection of information about patients not participating in clinical trials Preservation of samples	—

Countries

Japan

Contacts

Public ContactSouichi Adachi

Kyoto University Department of Medicine Human Health Sciences

adachiso@kuhp.kyoto-u.ac.jp075-751-3297

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026